Endothelial cell dysfunction: a key determinant for the outcome of allogeneic stem cell transplantation
2021 · Bone Marrow Transplantation · 72 citations
https://doi.org/10.1038/s41409-021-01390-y
A
Aleksandar Radujkovic
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
106
Papers
2.6K
Citations
27
h-index
43
i10-index
Aleksandar Radujkovic is an academic researcher from Heinrich Heine University Düsseldorf. The author has contributed to research in topics: Acute Myeloid Leukemia Research & Hematopoietic Stem Cell Transplantation & Chronic Myeloid Leukemia Treatments. The author has an h-index of 27, co-authored 91 publications.
ORCID: 0000-0002-8543-5016Papers by this author
worksSoluble receptor for advanced glycation end products (sRAGE) as a biomarker of COVID-19 disease severity and indicator of the need for mechanical ventilation, ARDS and mortality
2021 · Annals of Intensive Care · 70 citations
https://doi.org/10.1186/s13613-021-00836-2
EASIX for prediction of survival in lower-risk myelodysplastic syndromes
2019 · Blood Cancer Journal · 59 citations
https://doi.org/10.1038/s41408-019-0247-z
Letermovir prophylaxis is effective in preventing cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation: single-center real-world data
2020 · Annals of Hematology · 40 citations
https://doi.org/10.1007/s00277-020-04362-2
Donor Lymphocyte Infusions for Chronic Myeloid Leukemia Relapsing after Allogeneic Stem Cell Transplantation: May We Predict Graft-versus-Leukemia Without Graft-versus-Host Disease?
2015 · Biology of Blood and Marrow Transplantation · 39 citations
https://doi.org/10.1016/j.bbmt.2015.03.012
Aggressive Lymphoma after CD19 CAR T-Cell Therapy
2024 · New England Journal of Medicine · 34 citations
https://doi.org/10.1056/nejmoa2402730
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat